These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 16282744
1. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report]. Shinjo T, Okada M. Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744 [Abstract] [Full Text] [Related]
2. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S. Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696 [Abstract] [Full Text] [Related]
5. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Benítez-Rosario MA, Feria M, Salinas-Martín A, Martínez-Castillo LP, Martín-Ortega JJ. Cancer; 2004 Dec 15; 101(12):2866-73. PubMed ID: 15529307 [Abstract] [Full Text] [Related]
7. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial. Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L. Anticancer Res; 2001 Dec 15; 21(3C):2225-30. PubMed ID: 11501851 [Abstract] [Full Text] [Related]
8. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan]. Hashizume T, Tomiyasu S, Yomiya K, Yoshimoto T, Harada A, Matoba M, SCORE-G: Symptom Control Research Group. Gan To Kagaku Ryoho; 2007 Jun 15; 34(6):897-902. PubMed ID: 17570968 [Abstract] [Full Text] [Related]
9. [Usefulness of fentanyl patch (Durotep) in cancer patients when rotated from morphine preparations]. Akiyama Y, Iseki M, Izawa R, Ishii K, Miyazaki T, Yamaguchi S, Tani Y. Masui; 2007 Mar 15; 56(3):317-23. PubMed ID: 17366919 [Abstract] [Full Text] [Related]
10. [A case of long-term, high-dose transdermal fentanyl application for lung cancer pain]. Kamiya N, Yasogawa Y, Nishi Y, Takahashi Y, Kondo Y, Hirai T, Sakurai M, Masumizu K, Onosato W, Koyama T. Gan To Kagaku Ryoho; 2006 Mar 15; 33(3):377-80. PubMed ID: 16531723 [Abstract] [Full Text] [Related]
11. [Transdermal route as an alternative to oral administration of opioids in cancer pain]. Burza M, Ginobbi P, Fusco G, Laurenzi L, Tirelli W, Arcuri E. Clin Ter; 1998 Mar 15; 149(4):277-80. PubMed ID: 9866889 [Abstract] [Full Text] [Related]
14. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer]. Oztürk T, Karadibak K, Catal D, Cakan A, Tugsavul F, Cirak K. Agri; 2008 Jul 15; 20(3):20-5. PubMed ID: 19085178 [Abstract] [Full Text] [Related]
16. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life]. Yamazaki M, Aoki T, Tachibana M, Akashi T. Gan To Kagaku Ryoho; 2006 Feb 15; 33(2):217-21. PubMed ID: 16484859 [Abstract] [Full Text] [Related]
17. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy]. Zhen ZJ, Sun XF, Xia Y, Ling JY, Zheng L, Luo WB, Lin H. Ai Zheng; 2007 Aug 15; 26(8):866-9. PubMed ID: 17697549 [Abstract] [Full Text] [Related]
18. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J. Eur J Pain; 2009 Aug 15; 13(7):737-43. PubMed ID: 18977159 [Abstract] [Full Text] [Related]
19. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine]. Binhas M, Krakowski I, Marty J. Ann Fr Anesth Reanim; 2007 Jun 15; 26(6):502-15. PubMed ID: 17560755 [Abstract] [Full Text] [Related]